跳至主要内容
临床试验/NCT01573169
NCT01573169终止3 期

PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients

University Of Perugia1 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
73
试验地点
1
主要终点
Number of Participants With Symptomatic and Asymptomatic Venous Thromboembolism

研究概览

简要总结

Patients with cerebral hemorrhage (ICH) have a high risk of venous thromboembolism. Intermittent pneumatic compression combined with elastic stockings have been shown to be superior to elastic stockings alone in reducing the rate of asymptomatic deep vein thrombosis after ICH in a randomized trial (4.7% vs. 15.9%). Graduated compression stockings alone are ineffective in preventing deep vein thrombosis in patients with ischemic or hemorrhagic stroke. Less clear is the role of anticoagulation in the prevention of venous thromboembolism in patients with ICH because the use of anticoagulants may cause an enlargement of the hematoma. In a multicenter, randomized trial, the investigators will assess the efficacy and safety of enoxaparin in the prevention of venous thromboembolism in patients with spontaneous intracerebral hemorrhage. Enoxaparin (40 mg once daily) or standard therapy (graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization) will be given subcutaneously for not less than 10 days beginning after 72 hours from stroke onset.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Intracranial spontaneous hemorrhage on brain CT scan
  • Intracranial hemorrhage during treatment with oral anticoagulants
  • Bedridden patients (item 6 of NIHSS: motor leg points 3 or 4 or severe ataxia for cerebellar hemorrhage).

排除标准

  • cerebral hemorrhage due to intracranial vascular malformation
  • rebleeding on CT scan after 72 hours from stroke (before randomization)

研究组 & 干预措施

low weight molecular heparin

Experimental

enoxaparin 0.4 ml subcutaneous per day

干预措施: Enoxaparin (Drug)

standard therapy

Placebo Comparator

Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization

干预措施: Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization (Other)

结局指标

主要结局

Number of Participants With Symptomatic and Asymptomatic Venous Thromboembolism

时间窗: 10 days

Symptomatic venous thromboembolism (deep venous thrombosis and/or pulmonary embolism) and asymptomatic deep venous thrombosis on ultrasound examination

次要结局

  • Bleedings(90 days)
  • Mortality(90 days)
  • Disability(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maurizio Paciaroni

Principal Investigator

University Of Perugia

研究点 (1)

Loading locations...

相似试验